Model
Edge
Ultragenyx Pharmaceutical Inc.
0001713070
Filing Type
4
Filing Date
6/27/2022
Updated
6/28/22, 7:48 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership